Review article: evidence for the role of gut microbiota in irritable bowel syndrome and its potential influence on therapeutic targets

Global Prevalence of and Risk Factors for Irritable Bowel Syndrome: A Meta-analysis

Lovell, R. M., & Ford, A. C. (2012) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2012.02.029 · Cited by 2,155 · see citing works

The Intestinal Microbiota Affect Central Levels of Brain-Derived Neurotropic Factor and Behavior in Mice

Bercik, P., Denou, E., Collins, J., Jackson, W., Lu, J., Jury, J., Deng, Y., Blennerhassett, P., Macri, J., McCoy, K. D., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.04.052 · Cited by 1,748 · see citing works

The interplay between the intestinal microbiota and the brain

Collins, S. M., Surette, M., & Bercik, P. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2876 · Cited by 1,611 · cited 1× · see citing works

Lactobacillus and bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles

O’Mahony, L., McCarthy, J., Kelly, P., Hurley, G., Luo, F., Chen, K., O’Sullivan, G. C., Kiely, B., Collins, J. K., Shanahan, F., et al. (2005) · Gastroenterology · doi:10.1053/j.gastro.2004.11.050 · Cited by 1,448 · see citing works

Principles and clinical implications of the brain-gut-enteric microbiota axis

Rhee, S. H., Pothoulakis, C., & Mayer, E. A. (2009) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2009.35 · Cited by 1,342 · see citing works

Consumption of fermented milk product with probiotic modulates brain activity

Tillisch, K., Labus, J., Kilpatrick, L., Jiang, Z., Stains, J., Ebrat, B., Guyonnet, D., Legrain–Raspaud, S., Trotin, B., Naliboff, B., et al. (2013) · Gastroenterology · doi:10.1053/j.gastro.2013.02.043 · Cited by 1,192 · see citing works

The indigenous gastrointestinal microflora

Berg, R. (1996) · Trends in Microbiology · doi:10.1016/0966-842x(96)10057-3 · Cited by 1,153 · see citing works

Global and Deep Molecular Analysis of Microbiota Signatures in Fecal Samples From Patients With Irritable Bowel Syndrome

Rajilić–Stojanović, M., Biagi, E., Heilig, H. G. H. J., Kajander, K., Kekkonen, R. A., Tims, S., & de Vos, W. M. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.043 · Cited by 1,041 · see citing works

Rifaximin Therapy for Patients with Irritable Bowel Syndrome without Constipation

Pimentel, M., Lembo, A., Chey, W. D., Zakko, S., Ringel, Y., Yu, J., Mareya, S. M., Shaw, A. L., Bortey, E., & Forbes, W. P. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1004409 · Cited by 1,036 · see citing works

The Fecal Microbiota of Irritable Bowel Syndrome Patients Differs Significantly From That of Healthy Subjects

Kassinen, A., Krogius-Kurikka, L., Mäkivuokko, H., Rinttilä, T., Paulin, L., Corander, J., Malinen, E., Apajalahti, J., & Palva, A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.04.005 · Cited by 1,002 · see citing works

Intestinal microbiota in functional bowel disorders: a Rome foundation report

Simrén, M., Barbara, G., Flint, H. J., Spiegel, B. M. R., Spiller, R. C., Vanner, S., Verdu, E. F., Whorwell, P. J., & Zoetendal, E. G. (2013) · Gut · doi:10.1136/gutjnl-2012-302167 · Cited by 939 · see citing works

Activation of the mucosal immune system in irritable bowel syndrome

Chadwick, V. S., Chen, W., Shu, D., Paulus, B., Bethwaite, P., Tie, A., & Wilson, I. (2002) · Gastroenterology · doi:10.1053/gast.2002.33579 · Cited by 833 · see citing works

The impact of irritable bowel syndrome on health-related quality of life

Gralnek, I. M., Hays, R. D., Kilbourne, A., Naliboff, B., & Mayer, E. A. (2000) · Gastroenterology · doi:10.1053/gast.2000.16484 · Cited by 781 · see citing works

Eradication of Small Intestinal Bacterial Overgrowth Reduces Symptoms of Irritable Bowel Syndrome

Pimentel, M., Chow, E. J., & Lin, H. C. (2000) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.03368.x · Cited by 780 · see citing works

The efficacy of probiotics in the treatment of irritable bowel syndrome: a systematic review

Moayyedi, P., Ford, A. C., Talley, N. J., Cremonini, F., Foxx-Orenstein, A. E., Brandt, L. J., & Quigley, E. M. M. (2010) · Gut · doi:10.1136/gut.2008.167270 · Cited by 728 · see citing works

Normalization of lactulose breath testing correlates with symptom improvement in irritable bowel syndrome a double-blind, randomized, placebo-controlled study

Pimentel, M., Chow, E. J., & Lin, H. C. (2003) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2003.07234.x · Cited by 670 · see citing works

The neurobiology of stress and gastrointestinal disease

MAYER, E. A. (2000) · Gut · doi:10.1136/gut.47.6.861 · Cited by 666 · see citing works

The brain–gut pathway in functional gastrointestinal disorders is bidirectional: a 12-year prospective population-based study

Koloski, N. A., Jones, M., Kalantar, J., Weltman, M., Zaguirre, J., & Talley, N. J. (2012) · Gut · doi:10.1136/gutjnl-2011-300474 · Cited by 611 · see citing works

Clinical trial: The effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome

SILK, D. B. A., DAVIS, A., VULEVIC, J., TZORTZIS, G., & GIBSON, G. R. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2008.03911.x · Cited by 551 · see citing works

Linkage of gut microbiome with cognition in hepatic encephalopathy

Bajaj, J. S., Ridlon, J. M., Hylemon, P. B., Thacker, L. R., Heuman, D. M., Smith, S., Sikaroodi, M., & Gillevet, P. M. (2012) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00190.2011 · Cited by 547 · see citing works

The brain-gut axis in abdominal pain syndromes.

Mayer, E. A., & Tillisch, K. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-012309-103958 · Cited by 511 · see citing works

Systematic review and meta-analysis: the incidence and prognosis of post-infectious irritable bowel syndrome

THABANE, M., KOTTACHCHI, D. T., & MARSHALL, J. K. (2007) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2007.03399.x · Cited by 466 · see citing works

The Effect of a Nonabsorbed Oral Antibiotic (Rifaximin) on the Symptoms of the Irritable Bowel Syndrome: A Randomized Trial

Pimentel, M., Park, S., Mirocha, J., Kane, S. V., & Kong, Y. (2006) · Annals of Internal Medicine · doi:10.7326/0003-4819-145-8-200610170-00004 · Cited by 466 · see citing works

Specific probiotic therapy attenuates antibiotic induced visceral hypersensitivity in mice

Verdú, E. F., Bercik, P., Verma-Gandhu, M., Huang, X.-X., Blennerhassett, P., Jackson, W., Mao, Y., Wang, L., Rochat, F., & Collins, S. M. (2006) · Gut · doi:10.1136/gut.2005.066100 · Cited by 448 · see citing works

Effects of stressful life events on bowel symptoms: subjects with irritable bowel syndrome compared with subjects without bowel dysfunction.

Whitehead, W. E., Crowell, M. D., Robinson, J. C., Heller, B. R., & Schuster, M. M. (1992) · Gut · doi:10.1136/gut.33.6.825 · Cited by 432 · see citing works

Alterations in composition and diversity of the intestinal microbiota in patients with diarrhea‐predominant irritable bowel syndrome

Carroll, I. M., Ringel‐Kulka, T., Siddle, J. P., & Ringel, Y. (2012) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2012.01891.x · Cited by 425 · see citing works

Bulking agents, antispasmodics and antidepressants for the treatment of irritable bowel syndrome

Ruepert, L., Quartero, A. O., de Wit, N. J., van der Heijden, G. J., Rubin, G., & Muris, J. W. (2011) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003460.pub3 · Cited by 389 · see citing works

Gastrointestinal Illness and the Biopsychosocial Model

Drossman, D. A. (1998) · Psychosomatic Medicine · doi:10.1097/00006842-199805000-00007 · Cited by 388 · see citing works

Functional dysbiosis within the gut microbiota of patients with constipated‐irritable bowel syndrome

Chassard, C., Dapoigny, M. C., Scott, K. P., Crouzet, L., Del’Homme, C., Marquet, P., Martin, J. C., Pickering, G. P., Ardid, D., Eschalier, A., et al. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2012.05007.x · Cited by 366 · see citing works

Mechanisms of hypersensitivity in IBS and functional disorders

Azpiroz, F., Bouin, M., Camilleri, M., Mayer, E. A., Poitras, P., Serra, J., & Spiller, R. E. (2007) · Neurogastroenterology & Motility · doi:10.1111/j.1365-2982.2006.00875.x · Cited by 353 · see citing works

Postinfectious Irritable Bowel Syndrome-A Meta-Analysis

Halvorson, H. A., Schlett, C. D., & Riddle, M. S. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00654.x · Cited by 352 · see citing works

Small Intestinal Bacterial Overgrowth in Irritable Bowel Syndrome: Systematic Review and Meta-analysis

Ford, A. C., Spiegel, B. M. R., Talley, N. J., & Moayyedi, P. (2009) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.06.031 · Cited by 351 · see citing works

A Randomized Double-Blind Placebo-Controlled Trial of Rifaximin in Patients with Abdominal Bloating and Flatulence

Sharara, A. I., Aoun, E., Abdul-Baki, H., Mounzer, R., Sidani, S., & ElHajj, I. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00458.x · Cited by 344 · see citing works

Meta-analysis of probiotics for the treatment of irritable bowel syndrome

McFarland, L. V., & Dublin, S. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.2650 · Cited by 341 · see citing works

Faecal microbiota composition and host–microbe cross-talk following gastroenteritis and in postinfectious irritable bowel syndrome

Jalanka-Tuovinen, J., Salojärvi, J., Salonen, A., Immonen, O., Garsed, K., Kelly, F. M., Zaitoun, A., Palva, A., Spiller, R. C., & de Vos, W. M. (2014) · Gut · doi:10.1136/gutjnl-2013-305994 · Cited by 340 · see citing works

Voices from within: gut microbes and the CNS

Forsythe, P., & Kunze, W. A. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-1028-z · Cited by 336 · see citing works

Influence of microbial species on small intestinal myoelectric activity and transit in germ-free rats

Husebye, E., Hellström, P. M., Sundler, F., Chen, J., & Midtvedt, T. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.280.3.g368 · Cited by 319 · see citing works

The intestinal microbiota and chronic disorders of the gut

Dupont, A. W., & DuPont, H. L. (2011) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2011.133 · Cited by 306 · see citing works

A systematic review and meta-analysis: probiotics in the treatment of irritable bowel syndrome

Hoveyda, N., Heneghan, C., Mahtani, K. R., Perera, R., Roberts, N., & Glasziou, P. (2009) · BMC Gastroenterology · doi:10.1186/1471-230x-9-15 · Cited by 297 · see citing works

Molecular analysis of the luminal- and mucosal-associated intestinal microbiota in diarrhea-predominant irritable bowel syndrome

Carroll, I. M., Ringel-Kulka, T., Keku, T. O., Chang, Y.-H., Packey, C. D., Sartor, R. B., & Ringel, Y. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00154.2011 · Cited by 292 · see citing works

Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS

Yu, D., Cheeseman, F., & Vanner, S. (2011) · Gut · doi:10.1136/gut.2009.205476 · Cited by 284 · see citing works

The Efficacy and Safety of Rifaximin for the Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis

Menees, S. B., Maneerattannaporn, M., Kim, H. M., & Chey, W. D. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2011.355 · Cited by 283 · cited 1× · see citing works

The hypersensitivity to colonic distension of <scp>IBS</scp> patients can be transferred to rats through their fecal microbiota

Crouzet, L., Gaultier, E., Del'Homme, C., Cartier, C., Delmas, E., Dapoigny, M., Fioramonti, J., & Bernalier‐Donadille, A. (2013) · Neurogastroenterology &amp; Motility · doi:10.1111/nmo.12103 · Cited by 280 · cited 1× · see citing works

Rifaximin Alters Intestinal Bacteria and Prevents Stress-Induced Gut Inflammation and Visceral Hyperalgesia in Rats

Xu, D., Gao, J., Gillilland, M., Wu, X., Song, I., Kao, J. Y., & Owyang, C. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.10.026 · Cited by 271 · see citing works

Costs of Irritable Bowel Syndrome in the UK and US

Maxion‐Bergemann, S., Thielecke, F., Abel, F., & Bergemann, R. (2006) · PharmacoEconomics · doi:10.2165/00019053-200624010-00002 · Cited by 261 · see citing works

Durable Alteration of the Colonic Microbiota by the Administration of Donor Fecal Flora

Grehan, M., Borody, T. J., Leis, S., Campbell, J., Mitchell, H. M., & Wettstein, A. R. (2010) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e3181e5d06b · Cited by 253 · see citing works

A Molecular Analysis of Fecal and Mucosal Bacterial Communities in Irritable Bowel Syndrome

Codling, C., O’Mahony, L., Shanahan, F., Quigley, E. M. M., & Marchesi, J. R. (2010) · Digestive Diseases and Sciences · doi:10.1007/s10620-009-0934-x · Cited by 243 · see citing works

Bowel-flora alteration: a potential cure for inflammatory bowel disease and irritable bowel syndrome?

Borody, T. J., George, L., Andrews, P., Brandl, S., Noonan, S., Cole, P., Hyland, L., Morgan, A., Maysey, J., & Moore‐Jones, D. (1989) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1989.tb136704.x · Cited by 221 · see citing works

Impairment in work productivity and health-related quality of life in patients with IBS.

Dean, B. B., Aguilar, D., Barghout, V. E., Kahler, K. H., Frech, F. H., Groves, D., & Ofman, J. J. (2005) · PubMed · Cited by 210 · see citing works

Quantitative profiling of gut microbiota of children with diarrhea-predominant irritable bowel syndrome

Rigsbee, L., Agans, R., Shankar, V., Kenche, H., Khamis, H. J., Michail, S., & Paliy, O. (2012) · American Journal of Gastroenterology · doi:10.1038/ajg.2012.287 · Cited by 207 · see citing works

A Double-Blind Placebo-Controlled Trial with Loperamide in Irritable Bowel Syndrome

Efskind, P., Bernklev, T., & Vatn, M. H. (1996) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365529609006766 · Cited by 206 · see citing works

Distinct microbial populations exist in the mucosa‐associated microbiota of sub‐groups of irritable bowel syndrome

Parkes, G. C., Rayment, N. B., Hudspith, B. N., Petrovska, L., Lomer, M. C., Brostoff, J., Whelan, K., & Sanderson, J. D. (2012) · Neurogastroenterology &amp; Motility · doi:10.1111/j.1365-2982.2011.01803.x · Cited by 200 · see citing works

The Prevalence of Overgrowth by Aerobic Bacteria in the Small Intestine by Small Bowel Culture: Relationship with Irritable Bowel Syndrome

Pyleris, E., Giamarellos‐Bourboulis, E. J., Tzivras, D. M., Koussoulas, V., Barbatzas, C., & Pimentel, M. (2012) · Digestive Diseases and Sciences · doi:10.1007/s10620-012-2033-7 · Cited by 189 · see citing works

Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease

Whelan, K., & Quigley, E. M. M. (2013) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e32835d7bba · Cited by 183 · see citing works

Lactulose Breath Testing Does Not Discriminate Patients With Irritable Bowel Syndrome From Healthy Controls

Bratten, J. R., Spanier, J., & Jones, M. P. (2008) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2008.01785.x · Cited by 171 · see citing works

Synergy between Lactobacillus paracasei and its bacterial products to counteract stress-induced gut permeability and sensitivity increase in rats

Eutamene, H., Lamine, F., Chabo, C., Theodorou, V., Rochat, F., Bergonzelli, G. E., Corthésy-Theulaz, I., Fioramonti, J., & Bueno, L. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.8.1901 · Cited by 169 · see citing works

Altered peripheral toll-like receptor responses in the irritable bowel syndrome

McKernan, D. P., Gaszner, G., Quigley, E. M. M., Cryan, J. F., & Dinan, T. G. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04624.x · Cited by 160 · see citing works

Neomycin Improves Constipation-Predominant Irritable Bowel Syndrome in a Fashion That Is Dependent on the Presence of Methane Gas: Subanalysis of a Double-Blind Randomized Controlled Study

Pimentel, M., Chatterjee, S., Chow, E. J., Park, S., & Kong, Y. (2006) · Digestive Diseases and Sciences · doi:10.1007/s10620-006-9104-6 · Cited by 160 · see citing works

Probiotics and irritable bowel syndrome: a rationale for their use and an assessment of the evidence to date

Quigley, E. M. M., & Flourie, B. (2007) · Neurogastroenterology &amp; Motility · doi:10.1111/j.1365-2982.2006.00879.x · Cited by 151 · see citing works

The normal intestinal microbiota

Marchesi, J. R., & Shanahan, F. (2007) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e3282a56a99 · Cited by 136 · see citing works

Rifaximin versus Other Antibiotics in the Primary Treatment and Retreatment of Bacterial Overgrowth in IBS

Yang, J., Lee, H.-R., Low, K., Chatterjee, S., & Pimentel, M. (2008) · Digestive Diseases and Sciences · doi:10.1007/s10620-007-9839-8 · Cited by 129 · see citing works

Intestinal Microbiota and its Role in Irritable Bowel Syndrome (IBS)

Öhman, L., & Simrén, M. (2013) · Current Gastroenterology Reports · doi:10.1007/s11894-013-0323-7 · Cited by 123 · see citing works

Probiotics and prebiotics in the management of irritable bowel syndrome: a review of recent clinical trials and systematic reviews

Whelan, K. (2011) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/mco.0b013e32834b8082 · Cited by 120 · see citing works

Structural alterations of faecal and mucosa‐associated bacterial communities in irritable bowel syndrome

Durbán, A., Abellan, J. J., Jiménez‐Hernández, N., Salgado, P., Ponce, M., Ponce, J. D. C., Garrigues, V., Latorre, A., & Moyá, A. (2012) · Environmental Microbiology Reports · doi:10.1111/j.1758-2229.2012.00327.x · Cited by 110 · see citing works

Effect of probiotic species on irritable bowel syndrome symptoms: A bring up to date meta-analysis

Ortiz-Lucas, M., Aurelio, T., Saz, P., & Sebastián, J. J. (2013) · Revista Española de Enfermedades Digestivas · doi:10.4321/s1130-01082013000100005 · Cited by 103 · see citing works

Pretreatment of Epithelial Cells with Rifaximin Alters Bacterial Attachment and Internalization Profiles

Brown, E. L., Xue, Q., Jiang, Z., Xu, Y., & DuPont, H. L. (2009) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00691-09 · Cited by 96 · see citing works

Effect of probiotic bacteria on the intestinal microbiota in irritable bowel syndrome

Ng, S. C., Lam, E. F. C., Lam, T. T., Chan, Y., Law, W., Tse, P. C., Kamm, M. A., Sung, J. J. �., Chan, F. K. L., & Wu, J. C. Y. (2013) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.12306 · Cited by 94 · see citing works

Effects of Rifaximin Treatment and Retreatment in Nonconstipated IBS Subjects

Pimentel, M., Morales, W., Chua, K., Barlow, G., Weitsman, S., Kim, G., Amichai, M. M., Pokkunuri, V., Rook, E., Mathur, R., et al. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1728-5 · Cited by 86 · see citing works

Irritable bowel syndrome

Ford, A. C., & Talley, N. J. (2012) · BMJ · doi:10.1136/bmj.e5836 · Cited by 84 · see citing works

Instability of the faecal microbiota in diarrhoea-predominant irritable bowel syndrome

Durbán, A., Abellán, J. J., Jiménez-Hernández, N., Artacho, A., Garrigues, V., Ortiz, V., Ponce, J., Latorre, A., & Moya, A. (2013) · FEMS Microbiology Ecology · doi:10.1111/1574-6941.12184 · Cited by 83 · see citing works

Rifaximin-induced alteration of virulence of diarrhoea-producing Escherichia coli and Shigella sonnei

Jiang, Z., Shi, K., & DuPont, H. L. (2010) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2009.11.013 · Cited by 81 · see citing works

Effects of Bifidobacterium infantis 35624 on Post-Inflammatory Visceral Hypersensitivity in the Rat

Johnson, A. C., Greenwood-Van Meerveld, B., & McRorie, J. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1730-y · Cited by 76 · see citing works

Clinical Trial on the Efficacy of a New Symbiotic Formulation, Flortec, in Patients With Irritable Bowel Syndrome: A Multicenter, Randomized Study

Andriulli, A., Neri, M., Loguercio, C., Terreni, N., Merla, A., Cardarella, M. P., Federico, A., Chilovi, F., Milandri, G. L., De Bona, M., et al. (2008) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31817fadd6 · Cited by 75 · see citing works

Alterations in the Intestinal Microbiota and Functional Bowel Symptoms

Ringel, Y., & Carroll, I. M. (2009) · Gastrointestinal Endoscopy Clinics of North America · doi:10.1016/j.giec.2008.12.004 · Cited by 73 · see citing works

Rifaximin treatment for the irritable bowel syndrome with a positive lactulose hydrogen breath test improves symptoms for at least 3 months

Meyrat, P., Safroneeva, E., & Schoepfer, A. M. (2012) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12087 · Cited by 59 · see citing works

IBS-associated phylogenetic unbalances of the intestinal microbiota are not reverted by probiotic supplementation

Maccaferri, S., Candela, M., Turroni, S., Centanni, M., Severgnini, M., Consolandi, C., Cavina, P., & Brigidi, P. (2012) · Gut Microbes · doi:10.4161/gmic.21009 · Cited by 57 · see citing works

Current and future pharmacological treatments for diarrhea-predominant irritable bowel syndrome

Camilleri, M. (2013) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2013.794223 · Cited by 50 · see citing works

Multistrain probiotic preparation significantly reduces symptoms of irritable bowel syndrome in a double-blind placebo-controlled study.

Cui, S., & Hu, Y. (2012) · PubMed · Cited by 45 · see citing works

The Rationale and Clinical Effectiveness of Probiotics in Irritable Bowel Syndrome

Ringel, Y., & Ringel-Kulka, T. (2011) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e31822d32d3 · Cited by 44 · see citing works

Biologic properties and clinical uses of rifaximin

DuPont, H. L. (2011) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2011.546347 · Cited by 43 · see citing works

Antibiotics for Irritable Bowel Syndrome: Rationale and Current Evidence

Sachdev, A. H., & Pimentel, M. (2012) · Current Gastroenterology Reports · doi:10.1007/s11894-012-0284-2 · Cited by 40 · see citing works

Effects of symbiotic preparations on constipated irritable bowel syndrome symptoms.

Dughera, L., Elia, C., Navino, M., & Cisarò, F. (2007) · Acta bio-medica dell'Ateneo parmense/Acta biomedica · Cited by 35 · see citing works

Pathogenic Factors Involved in the Development of Irritable Bowel Syndrome: Focus on a Microbial Role

Bolino, C., & Berčík, P. (2010) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2010.07.005 · Cited by 34 · see citing works

Irritable bowel syndrome: the role of the intestinal microbiota, pathogenesis and therapeutic targets.

Dahlqvist, G., & Piessevaux, H. H. (2011) · PubMed · Cited by 30 · see citing works

Inflammation and Microflora

Pimentel, M., & Chang, C. C.-C. (2011) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2010.12.010 · Cited by 30 · see citing works

Treatments targeting putative mechanisms in irritable bowel syndrome

Cremonini, F., & Talley, N. J. (2005) · Nature Clinical Practice Gastroenterology &#38 Hepatology · doi:10.1038/ncpgasthep0096 · Cited by 23 · see citing works

Microbiota, Innate Immune System, and Gastrointestinal Muscle

Tattoli, I., Petitta, C., Scirocco, A., Ammoscato, F., Cicenia, A., & Severi, C. (2012) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0b013e318265ea7d · Cited by 21 · see citing works

Bacterial concepts in irritable bowel syndrome.

Lin, H. C., & Pimentel, M. (2005) · PubMed · Cited by 19 · see citing works

Review: Do patients with functional gastrointestinal disorders have an altered gut flora?

Quigley, E. M. M. (2009) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x09335636 · Cited by 17 · see citing works

Targeted therapies for diarrhea-predominant irritable bowel syndrome

Olden, K. W. (2012) · Clinical and Experimental Gastroenterology · doi:10.2147/ceg.s29023 · Cited by 15 · see citing works

Long-Term Outcome of Rifaximin Therapy in Non-constipation Irritable Bowel Syndrome

Weinstock, L. B. (2011) · Digestive Diseases and Sciences · doi:10.1007/s10620-011-1889-2 · Cited by 11 · see citing works

Irritable Bowel Syndrome: a Review -

Kumar, A., Rinwa, P., & Sharma, N. (2012) · Journal of Physiology and Pharmacology Advances · Cited by 11 · see citing works

The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems.

(2015) · PubMed Central · Cited by 2,540 · see citing works

Irritable Bowel Syndrome

Chey, W. D., Kurlander, J. E., & Eswaran, S. L. (2015) · JAMA · doi:10.1001/jama.2015.0954 · Cited by 1,086 · see citing works

Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease

Imhann, F., Vich Vila, A., Bonder, M. J., Fu, J., Gevers, D., Visschedijk, M. C., Spekhorst, L. M., Alberts, R., Franke, L., van Dullemen, H. M., et al. (2018) · Gut · doi:10.1136/gutjnl-2016-312135 · Cited by 788 · see citing works

Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low <scp>FODMAP</scp> diet in children with the irritable bowel syndrome

Chumpitazi, B. P., Cope, J. L., Hollister, E. B., Tsai, C. M., McMeans, A. R., Luna, R. A., Versalovic, J., & Shulman, R. J. (2015) · Alimentary Pharmacology &amp; Therapeutics · doi:10.1111/apt.13286 · Cited by 436 · see citing works

Composition and temporal stability of the gut microbiota in older persons

Jeffery, I. B., Lynch, D. B., & O’Toole, P. W. (2016) · The ISME Journal · doi:10.1038/ismej.2015.88 · Cited by 421 · see citing works

The Gut-Brain Axis: Influence of Microbiota on Mood and Mental Health.

Appleton, J. (2018) · Europe PMC (PubMed Central) · Cited by 337 · see citing works

<scp>GABA</scp> ‐producing <i>Bifidobacterium dentium</i> modulates visceral sensitivity in the intestine

Pokusaeva, K., Johnson, C., Luk, B., Uribe, G., Fu, Y., Oezguen, N., Matsunami, R. K., Lugo, M., Major, A., Mori‐Akiyama, Y., et al. (2017) · Neurogastroenterology &amp; Motility · doi:10.1111/nmo.12904 · Cited by 337 · see citing works

The Microbiome and Irritable Bowel Syndrome – A Review on the Pathophysiology, Current Research and Future Therapy

Chong, P.-P., Chin, V., Looi, C., Wong, W., Madhavan, P., & Yong, V. C. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01136 · Cited by 293 · see citing works

Microbiota regulation of the mammalian gut-brain axis

Burokas, A., Moloney, R. D., Dinan, T. G., & Cryan, J. F. (2015) · Advances in applied microbiology · doi:10.1016/bs.aambs.2015.02.001 · Cited by 300 · see citing works

Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD

Casèn, C., Vebø, H. C., Sekelja, M., Hegge, F. T., Karlsson, M. K., Ciemniejewska, E., Dzankovic, S., Frøyland, C., Nestestog, R., Engstrand, L. G., et al. (2015) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.13236 · Cited by 286 · see citing works

Disturbance of the gut microbiota in early-life selectively affects visceral pain in adulthood without impacting cognitive or anxiety-related behaviors in male rats

O’Mahony, S. M., Felice, V. D., Nally, K., Savignac, H. M., Claesson, M. J., Scully, P., Woznicki, J., Hyland, N. P., Shanahan, F., Quigley, E. M., et al. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.07.054 · Cited by 272 · see citing works

Altered molecular signature of intestinal microbiota in irritable bowel syndrome patients compared with healthy controls: A systematic review and meta-analysis

Liu, H.-N., Wu, H., Chen, Y.-Z., Chen, Y.-J., Shen, X.-Z., & Liu, T.-T. (2017) · Digestive and Liver Disease · doi:10.1016/j.dld.2017.01.142 · Cited by 254 · see citing works

The intestinal microbiome, barrier function, and immune system in inflammatory bowel disease: a tripartite pathophysiological circuit with implications for new therapeutic directions

Vindigni, S. M., Zisman, T. L., Suskind, D. L., & Damman, C. J. (2016) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x16644242 · Cited by 228 · see citing works

Fecal and Mucosal Microbiota Profiling in Irritable Bowel Syndrome and Inflammatory Bowel Disease

Presti, A. L., Zorzi, F., Chierico, F. D., Altomare, A., Cocca, S., Avola, A., Biasio, F. D., Russo, A., Cella, E., Reddel, S., et al. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.01655 · Cited by 198 · see citing works

A Review of Microbiota and Irritable Bowel Syndrome: Future in Therapies

Rodiño‐Janeiro, B. K., Vicario, M., Alonso, C., Pascua-García, R., & Santos, J. (2018) · Advances in Therapy · doi:10.1007/s12325-018-0673-5 · Cited by 211 · see citing works

Effects of probiotic type, dose and treatment duration on irritable bowel syndrome diagnosed by Rome III criteria: a meta-analysis

Zhang, Y., Li, L., Guo, C., Mu, D., Feng, B., Zuo, X., & Li, Y. (2016) · BMC Gastroenterology · doi:10.1186/s12876-016-0470-z · Cited by 182 · see citing works

Long-term irritable bowel syndrome symptom control with reintroduction of selected FODMAPs

Harvie, R. M., Chisholm, A. W., Bisanz, J. E., Burton, J. P., Herbison, P., Schultz, K., & Schultz, M. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i25.4632 · Cited by 143 · see citing works

Lactobacillus casei DG and its postbiotic reduce the inflammatory mucosal response: an ex-vivo organ culture model of post-infectious irritable bowel syndrome

Compare, D., Rocco, A., Coccoli, P., Angrisani, D., Sgamato, C., Iovine, B., Salvatore, U., & Nardone, G. (2017) · BMC Gastroenterology · doi:10.1186/s12876-017-0605-x · Cited by 133 · see citing works

Antibiotic-Induced Depletion of Murine Microbiota Induces Mild Inflammation and Changes in Toll-Like Receptor Patterns and Intestinal Motility

Grasa, L., Abecia, L., Forcén, R., Castro, M., de Jalón, J. A. G., Latorre, E., Alcalde, A. I., & Murillo, M. D. (2015) · Microbial Ecology · doi:10.1007/s00248-015-0613-8 · Cited by 128 · see citing works

A decrease in iron availability to human gut microbiome reduces the growth of potentially pathogenic gut bacteria; an in vitro colonic fermentation study

Parmanand, B. A., Kellingray, L., Le Gall, G., Basit, A. W., Fairweather-Tait, S., & Narbad, A. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.01.010 · Cited by 110 · see citing works

Unexpected improvement in core autism spectrum disorder symptoms after long-term treatment with probiotics

Grossi, E., Melli, S., Dunca, D., & Terruzzi, V. (2016) · SAGE Open Medical Case Reports · doi:10.1177/2050313x16666231 · Cited by 113 · see citing works

Faecal short-chain fatty acids - a diagnostic biomarker for irritable bowel syndrome?

Farup, P. G., Rudi, K., & Hestad, K. A. (2016) · BMC Gastroenterology · doi:10.1186/s12876-016-0446-z · Cited by 103 · see citing works

Gut–brain axis biochemical signalling from the gastrointestinal tract to the central nervous system: gut dysbiosis and altered brain function

Arneth, B. M. (2018) · Postgraduate Medical Journal · doi:10.1136/postgradmedj-2017-135424 · Cited by 104 · see citing works

Visceral pain: gut microbiota, a new hope?

Pusceddu, M. M., & Gareau, M. G. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0476-7 · Cited by 100 · see citing works

Differences of microbiota in small bowel and faeces between irritable bowel syndrome patients and healthy subjects

Chung, C., Chang, P., Liao, C., Lee, T., Chen, Y., Lee, Y., Wu, M., Wang, H., & Ni, Y. (2015) · Scandinavian Journal of Gastroenterology · doi:10.3109/00365521.2015.1116107 · Cited by 101 · see citing works

Metabolome of human gut microbiome is predictive of host dysbiosis

Larsen, P. E., & Dai, Y. D. (2015) · GigaScience · doi:10.1186/s13742-015-0084-3 · Cited by 98 · see citing works

Efficacy and Safety of Probiotics in Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis

Li, B., Li, L., Deng, H., Guo, J., Shu, H., & Zhang, L. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00332 · Cited by 95 · see citing works

Relief of irritable bowel syndrome by fecal microbiota transplantation is associated with changes in diversity and composition of the gut microbiota

Huang, H. L., Chen, H. T., Luo, Q. L., Xu, H. M., He, J., Li, Y. Q., Zhou, Y. L., Yao, F., Nie, Y. Q., & Zhou, Y. J. (2019) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12756 · Cited by 89 · see citing works

Overlapping irritable bowel syndrome and inflammatory bowel disease: less to this than meets the eye?

Quigley, E. M. M. (2015) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x15621230 · Cited by 86 · see citing works

Gut dysbiosis and irritable bowel syndrome: The potential role of probiotics

Principi, N., Cozzali, R., Farinelli, E., Brusaferro, A., & Esposito, S. (2017) · Journal of Infection · doi:10.1016/j.jinf.2017.12.013 · Cited by 84 · see citing works

Artificial intelligence-based personalized diet: A pilot clinical study for irritable bowel syndrome

Karakan, T., Gündoğdu, A., Alagözlü, H., Ekmen, N., Özgül, S., Tunalı, V., Hora, M., Beyazgül, D., & Nalbantoğlu, Ö. U. (2022) · Gut Microbes · doi:10.1080/19490976.2022.2138672 · Cited by 80 · see citing works

A proof-of-concept study showing antibiotics to be more effective in irritable bowel syndrome with than without small-intestinal bacterial overgrowth

Ghoshal, U. C., Srivastava, D., Misra, A., & Ghoshal, U. (2016) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0000000000000557 · Cited by 80 · see citing works

Fecal Microbiota Transplantation for Inflammatory Bowel Disease.

Lopez, J., & Grinspan, A. M. (2016) · PubMed Central · Cited by 75 · see citing works

Effect of administering a multi-species probiotic mixture on the changes in fecal microbiota and symptoms of irritable bowel syndrome: a randomized, double-blind, placebo-controlled trial

Yoon, H., Park, Y. S., Lee, D. H., Seo, J., Shin, C. M., & Kim, N. (2015) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.15-14 · Cited by 66 · see citing works

Tong-Xie-Yao-Fang Regulates 5-HT Level in Diarrhea Predominant Irritable Bowel Syndrome Through Gut Microbiota Modulation

Li, J., Cui, H., Cai, Y., Lin, J., Song, X., Zhou, Z., Xiong, W.-T., Zhou, H., Bian, Y., & Wang, L. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.01110 · Cited by 64 · see citing works

New therapeutic perspectives in irritable bowel syndrome: Targeting low-grade inflammation, immuno-neuroendocrine axis, motility, secretion and beyond

Sinagra, E., Morreale, G., Mohammadian, G., Fusco, G., Guarnotta, V., Tomasello, G., Cappello, F., Rossi, F., Amvrosiadis, G., & Raimondo, D. (2017) · World Journal of Gastroenterology · doi:10.3748/wjg.v23.i36.6593 · Cited by 52 · see citing works

The Intestinal Microbiota and Irritable Bowel Syndrome

Ringel, Y., & Ringel‐Kulka, T. (2015) · Journal of Clinical Gastroenterology · doi:10.1097/mcg.0000000000000418 · Cited by 54 · see citing works

Serotonergic reinforcement of intestinal barrier function is impaired in irritable bowel syndrome

Keszthelyi, D., Troost, F. J., Jonkers, D. M. A. E., van Eijk, H. M. H., Lindsey, P. J., Dekker, J. P., Buurman, W. A., & Masclee, A. (2014) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.12842 · Cited by 53 · see citing works

An overview on the interplay between nutraceuticals and gut microbiota

Cătinean, A., Neag, M. A., Muntean, D. M., Bocșan, I. C., & Buzoianu, A. D. (2018) · PeerJ · doi:10.7717/peerj.4465 · Cited by 53 · see citing works

The Newest “Omics”—Metagenomics and Metabolomics—Enter the Battle against the Neglected Tropical Diseases

Preidis, G. A., & Hotez, P. J. (2015) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0003382 · Cited by 51 · see citing works

Systematic review: ileoanal pouch microbiota in health and disease

Segal, J. P., Oke, S., Hold, G. L., Clark, S. K., Faiz, O. D., & Hart, A. L. (2017) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.14454 · Cited by 51 · see citing works

Human microbiome restoration and safety

Daliri, E. B., Tango, C. N., Lee, B. H., & Oh, D. (2018) · International Journal of Medical Microbiology · doi:10.1016/j.ijmm.2018.05.002 · Cited by 49 · see citing works

Efficacy of combination therapy with probiotics and mosapride in patients with<scp>IBS</scp>without diarrhea: a randomized, double‐blind, placebo‐controlled, multicenter, phase II trial

Choi, C. H., Kwon, J. G., Kim, S. K., Myung, S. ‐., Park, K. S., Sohn, C. ‐., Rhee, P. ‐., Lee, K. J., Lee, O. Y., Jung, H. ‐., et al. (2015) · Neurogastroenterology &amp; Motility · doi:10.1111/nmo.12544 · Cited by 46 · see citing works

Irritable Bowel Syndrome

Mullin, G. E., Shepherd, S. J., Roland, B. C., Ireton-Jones, C. S., & Matarese, L. E. (2014) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607114545329 · Cited by 44 · see citing works

The effects of administration of theLactobacillus gasseristrain CP2305 on quality of life, clinical symptoms and changes in gene expression in patients with irritable bowel syndrome

Nobutani, K., Sawada, D., Fujiwara, S., Kuwano, Y., Nishida, K., Nakayama, J., Kutsumi, H., Azuma, T., & Rokutan, K. (2016) · Journal of Applied Microbiology · doi:10.1111/jam.13329 · Cited by 42 · see citing works

Effectiveness and Safety of Probiotics for Patients with Constipation-Predominant Irritable Bowel Syndrome: A Systematic Review and Meta-Analysis of 10 Randomized Controlled Trials

Shang, X., E, F.-F., Guo, K.-L., Li, Y.-F., Zhao, H.-L., Wang, Y., Chen, N., Nian, T., Yang, C.-Q., Yang, K.-H., et al. (2022) · Nutrients · doi:10.3390/nu14122482 · Cited by 41 · see citing works

Giardia Infection of the Small Intestine Induces Chronic Colitis in Genetically Susceptible Hosts

Dann, S. M., Le, C., Hanson, E. M., Ross, M. C., & Eckmann, L. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1700824 · Cited by 40 · see citing works

The Gut Microbiome in Irritable Bowel Syndrome and Other Functional Bowel Disorders

Ringel, Y. (2017) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2016.09.014 · Cited by 39 · see citing works

Fecal Microbiota Transplantation: A Review of Emerging Indications Beyond Relapsing Clostridium difficile Toxin Colitis.

Lee, W. J., Lattimer, L., Stephen, S., Borum, M. L., & Doman, D. B. (2015) · PubMed Central · Cited by 38 · see citing works

Diarrhea‐predominant irritable bowel syndrome: Diagnosis, etiology, and new treatment considerations

Lacy, B., & Moreau, J. (2016) · Journal of the American Association of Nurse Practitioners · doi:10.1002/2327-6924.12387 · Cited by 37 · see citing works

Advances in IBS 2016: A Review of Current and Emerging Data.

Jacobson, I. M. (2016) · PubMed Central · Cited by 38 · see citing works

Migraine in young females with irritable bowel syndrome: still a challenge

Georgescu, D., Reisz, D., Gurban, C., Georgescu, L., Ioniță, I., Ancusa, O., & Lighezan, D. (2017) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s144955 · Cited by 38 · see citing works

Long-term Clinical Course of Post-infectious Irritable Bowel Syndrome After Shigellosis: A 10-year Follow-up Study

Youn, Y. H., Kim, H. C., Lim, H. C., Park, J. J., Kim, J., & Park, H. (2016) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm15157 · Cited by 37 · see citing works

Viral metagenomic analysis of fecal samples reveals an enteric virome signature in irritable bowel syndrome

Ansari, M., Ebrahimi, M., Fattahi, M. R., Gardner, M., Safarpour, A. R., Faghihi, M. A., & Lankarani, K. B. (2020) · BMC Microbiology · doi:10.1186/s12866-020-01817-4 · Cited by 38 · see citing works

New psychological therapies for irritable bowel syndrome: Mindfulness, acceptance and commitment therapy (ACT)

Sebastián Sánchez, B., Gil Roales-Nieto, J., Ferreira, N. B., Gil Luciano, B., & Sebastián Domingo, J. J. (2017) · Revista Espanola de Enfermedades Digestivas · doi:10.17235/reed.2017.4660/2016 · Cited by 36 · see citing works

Therapeutic Effects and Mechanisms of Action of Rifaximin in Gastrointestinal Diseases

DuPont, H. L. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.04.016 · Cited by 36 · see citing works

Prebiotics and probiotics in irritable bowel syndrome and inflammatory bowel disease in children

Guandalini, S., Cernat, E., & Moscoso, D. I. (2014) · Beneficial Microbes · doi:10.3920/bm2014.0067 · Cited by 36 · see citing works

Update on the Management of Diarrhea‐Predominant Irritable Bowel Syndrome: Focus on Rifaximin and Eluxadoline

Rivkin, A. M., & Rybalov, S. (2016) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1712 · Cited by 35 · see citing works

Involvement of shared mucosal‐associated microbiota in the duodenum and rectum in diarrhea‐predominant irritable bowel syndrome

Li, G., Yang, M. J., Jin, Y. T., Li, Y., Qian, W., Xiong, H., Song, J., & Hou, X. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14059 · Cited by 35 · see citing works

Gut-brain axis and Alzheimer's disease: Therapeutic interventions and strategies

Singh, H., Chopra, C., Singh, H., Malgotra, V., Wani, A. K., Dhanjal, D. S., Sharma, I., Nepovimová, E., Alomar, S. Y., Singh, R., et al. (2023) · Journal of Functional Foods · doi:10.1016/j.jff.2023.105915 · Cited by 41 · see citing works

Blastocystis Isolates from Patients with Irritable Bowel Syndrome and from Asymptomatic Carriers Exhibit Similar Parasitological Loads, but Significantly Different Generation Times and Genetic Variability across Multiple Subtypes

Vargas-Sanchez, G.-B., Romero‐Valdovinos, M., Ramirez-Guerrero, C., Vargas-Hernandez, I., Ramírez-Miranda, M. E., Martínez-Ocaña, J., Valadéz, A., Ximénez, C., López-Escamilla, E., Hernández‐Campos, M. E., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124006 · Cited by 34 · see citing works

Irritable Bowel Syndrome: Pathophysiology and Current Therapeutic Approaches.

Camilleri, M., & Ford, A. (2017) · Handbook of Experimental Pharmacology · doi:10.1007/164_2016_102 · Cited by 33 · see citing works

Increased Expression of Colonic Mucosal Melatonin in Patients with Irritable Bowel Syndrome Correlated with Gut Dysbiosis

Wang, B., Zhu, S., Liu, Z., Wei, H., Zhang, L., He, M., Pei, F., Zhang, J., Sun, Q., & Duan, L. (2020) · Genomics Proteomics & Bioinformatics · doi:10.1016/j.gpb.2020.06.013 · Cited by 33 · see citing works

Altered profiles of fecal metabolites correlate with visceral hypersensitivity and may contribute to symptom severity of diarrhea-predominant irritable bowel syndrome

Zhang, W.-X., Zhang, Y., Qin, G., Li, K.-M., Wei, W., Li, S.-Y., & Yao, S.-K. (2019) · World Journal of Gastroenterology · doi:10.3748/wjg.v25.i43.6416 · Cited by 32 · see citing works

Probiotics in functional bowel disorders

Hod, K., & Ringel, Y. (2016) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2016.01.003 · Cited by 33 · see citing works

The Role of Intestinal Microbiota and Mast Cell in a Rat Model of Visceral Hypersensitivity

Li, Y., Li, J., & Dai, C. (2020) · Journal of Neurogastroenterology and Motility · doi:10.5056/jnm20004 · Cited by 32 · see citing works

Changes in Fecal Short-Chain Fatty Acids in IBS Patients and Effects of Different Interventions: A Systematic Review and Meta-Analysis

Ju, X., Jiang, Z., Ma, J., & Yang, D. J. (2024) · Nutrients · doi:10.3390/nu16111727 · Cited by 37 · see citing works

Fecal microbiota transplantation for COVID-19; a potential emerging treatment strategy

Nejadghaderi, S. A., Mojarad, E. N., & Aghdaei, H. A. (2020) · Medical Hypotheses · doi:10.1016/j.mehy.2020.110476 · Cited by 30 · see citing works

Irritable bowel syndrome: an integrated explanatory model for clinical practice

Hungin, A. P. S., Becher, A., Cayley, B., Heidelbaugh, J. J., Muris, J. W. M., Rubin, G. P., Seifert, B., Russell, A., & de Wit, N. J. (2015) · Neurogastroenterology & Motility · doi:10.1111/nmo.12524 · Cited by 31 · see citing works

Microbiome, antibiotics and irritable bowel syndrome

Ahmad, O. F., & Akbar, A. (2016) · British Medical Bulletin · doi:10.1093/bmb/ldw038 · Cited by 30 · see citing works

Natural Useful Therapeutic Products from Microbes

Gupta, C. (2014) · Journal of Microbiology & Experimentation · doi:10.15406/jmen.2014.01.00006 · Cited by 29 · see citing works

Clinical pilot study: efficacy of triple antibiotic therapy in Blastocystis positive irritable bowel syndrome patients

Nagel, R., Bielefeldt‐Ohmann, H., & Traub, R. J. (2014) · Gut Pathogens · doi:10.1186/s13099-014-0034-0 · Cited by 25 · see citing works

Adult Stress Promotes Purinergic Signaling to Induce Visceral Pain in Rats with Neonatal Maternal Deprivation

Hu, S., Sun, Q., Du, W., Song, J., Li, X., Zhang, P., Xu, J., & Xu, G. (2020) · Neuroscience Bulletin · doi:10.1007/s12264-020-00575-7 · Cited by 25 · see citing works

THE INTESTINAL MICROBIOTA AND THE ROLE OF PROBIOTICS IN IRRITABLE BOWEL SYNDROME: a review

Moraes-Filho, J. P. P., & Quigley, E. M. M. (2015) · Arquivos de Gastroenterologia · doi:10.1590/s0004-28032015000400015 · Cited by 25 · see citing works

Rifaximin for the treatment of irritable bowel syndrome – a drug safety evaluation

Ponziani, F. R., Pecere, S., Lopetuso, L. R., Scaldaferri, F., Cammarota, G., & Gasbarrini, A. (2016) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2016.1186639 · Cited by 24 · see citing works

Trait Energy and Fatigue May Be Connected to Gut Bacteria among Young Physically Active Adults: An Exploratory Study

Boolani, A., Gallivan, K. M., Ondrak, K. S., Christopher, C. J., Castro, H. F., Campagna, S. R., Taylor, C. M., Luo, M., Dowd, S. E., Smith, M. L., et al. (2022) · Nutrients · doi:10.3390/nu14030466 · Cited by 24 · see citing works

Phylogenetic analysis of Prevotella copri from fecal and mucosal microbiota of IBS and IBD patients

Presti, A. L., CHIERICO, F. D., Altomare, A., Zorzi, F., Monteleone, G., Putignani, L., Angeletti, S., Cicala, M., Guarino, M. P. L., & Ciccozzi, M. (2023) · Therapeutic Advances in Gastroenterology · doi:10.1177/17562848221136328 · Cited by 24 · see citing works

Perinatal and familial risk factors for irritable bowel syndrome in a Swedish national cohort

Waehrens, R., Li, X., Sundquist, J., Sundquist, K., & Zöller, B. (2017) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2017.1398345 · Cited by 24 · see citing works

Effects of Alkaline‐Reduced Drinking Water on Irritable Bowel Syndrome with Diarrhea: A Randomized Double‐Blind, Placebo‐Controlled Pilot Study

Shin, D. W., Yoon, H., Kim, H. S., Choi, Y. J., Shin, C. M., Park, Y. S., Kim, N., & Lee, D. H. (2018) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2018/9147914 · Cited by 24 · see citing works

Methane and Constipation-predominant Irritable Bowel Syndrome: Entwining Pillars of Emerging Neurogastroenterology

Waqar, S. H. B., & Rehan, A. (2019) · Cureus · doi:10.7759/cureus.4764 · Cited by 23 · see citing works

Therapeutic implications of SARS-CoV-2 dysregulation of the gut-brain-lung axis

Johnson, S. D., Olwenyi, O. A., Bhyravbhatla, N., Thurman, M., Pandey, K., Klug, E., Johnston, M., Dyavar, S. R., Acharya, A., Podany, A. T., et al. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v27.i29.4763 · Cited by 22 · see citing works

Glutamine Supplementation Enhances the Effects of a Low FODMAP Diet in Irritable Bowel Syndrome Management

Rastgoo, S., Ebrahimi‐Daryani, N., Agah, S., Karimi, S., Taher, M., Rashidkhani, B., Hejazi, E., Mohseni, F., Ahmadzadeh, M., Sadeghi, A., et al. (2021) · Frontiers in Nutrition · doi:10.3389/fnut.2021.746703 · Cited by 20 · see citing works

Drugging the microbiome and bacterial live biotherapeutic consortium production

McChalicher, C. W. J., & Aunins, J. G. (2022) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2022.102801 · Cited by 21 · see citing works

Evaluation of Escherichia coli pathotypes associated with Irritable Bowel Syndrome

Dogan, B., Belcher-Timme, H. F., Dogan, E. I., Jiang, Z., DuPont, H. L., Synder, N., Yang, S. C., Chandler, B., Scherl, E., & Simpson, K. W. (2018) · FEMS Microbiology Letters · doi:10.1093/femsle/fny249 · Cited by 19 · see citing works

Value-based Pricing for Rifaximin Increases Access of Patients With Irritable Bowel Syndrome With Diarrhea to Therapy

Shah, E. D., Saini, S., & Chey, W. (2019) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2019.02.039 · Cited by 13 · see citing works

Global research progress of visceral hypersensitivity and irritable bowel syndrome: bibliometrics and visualized analysis

Tian, S. I. P., Zhang, H., Chen, S., Wu, P.-N., & Chen, M. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1175057 · Cited by 19 · see citing works

Rifaximin for the treatment of diarrhoea-predominant irritable bowel syndrome

Laterza, L., Ianiro, G., Scoleri, I., Landi, R., Bruno, G., Scaldaferri, F., Gaetani, E., Campanale, M., & Gasbarrini, A. (2015) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2015.1007951 · Cited by 18 · see citing works

Validation and application of an ultrahigh-performance liquid chromatographic-Orbitrap mass spectrometric method for the simultaneous detection and quantification of volatile and non-volatile organic acids in human faecal samples

Gardana, C., Bo’, C. D., & Simonetti, P. (2017) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2017.04.006 · Cited by 18 · see citing works

Neonatal Maternal Deprivation Followed by Adult Stress Enhances Adrenergic Signaling to Advance Visceral Hypersensitivity

Du, W., Hu, S., Li, X., Zhang, P., Jiang, X., Yu, S.-P., & Xu, G. (2018) · Neuroscience Bulletin · doi:10.1007/s12264-018-0318-3 · Cited by 18 · see citing works

Pharmacokinetic drug evaluation of rifaximin for treatment of diarrhea-predominant irritable bowel syndrome

Bruzzese, E., Pesce, M., Sarnelli, G., & Guarino, A. (2018) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1080/17425255.2018.1488964 · Cited by 18 · see citing works

Common functional pain syndromes

Crabtree, D., & Ganty, P. (2016) · BJA Education · doi:10.1093/bjaed/mkw010 · Cited by 16 · see citing works

Microbiota- Brain-Gut-Axis Relevance to Parkinson’s Disease: Potential Therapeutic Effects of Probiotics

Raj, K., Singh, S., Chib, S., & Mallan, S. (2022) · Current Pharmaceutical Design · doi:10.2174/1381612828666221003112300 · Cited by 16 · see citing works

Bridging the Mind and Gut: Uncovering the Intricacies of Neurotransmitters, Neuropeptides, and their Influence on Neuropsychiatric Disorders

Gupta, S., Dinesh, S., & Sharma, S. (2024) · Central Nervous System Agents in Medicinal Chemistry · doi:10.2174/0118715249271548231115071021 · Cited by 16 · see citing works

Efficacy and safety of biophenol‐rich nutraceuticals in adults with inflammatory gastrointestinal diseases or irritable bowel syndrome: A systematic literature review and meta‐analysis

Giang, J., Lan, X., Crichton, M., Marx, W., & Marshall, S. (2021) · Nutrition & Dietetics · doi:10.1111/1747-0080.12672 · Cited by 15 · see citing works

Eluxadoline in the treatment of diarrhea-predominant irritable bowel syndrome

Özdener, A. E., & Rivkin, A. (2017) · Drug Design, Development and Therapy · doi:10.2147/dddt.s127405 · Cited by 16 · see citing works

Risk of cancer in patients with irritable bowel syndrome: a nationwide population-based study

Hu, L., Ku, F., Lu, T., Shen, C.-C., Hu, Y., Yeh, C., Tzeng, C., Chen, T., Chen, P., & Liu, C. (2015) · Annals of Epidemiology · doi:10.1016/j.annepidem.2015.07.006 · Cited by 14 · see citing works

GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN GASTROINTESTINAL AND LIVER DISEASES: PROCEEDINGS OF A JOINT MEETING OF THE BRAZILIAN SOCIETY OF HEPATOLOGY (SBH), BRAZILIAN NUCLEUS FOR THE STUDY OF HELICOBACTER PYLORI AND MICROBIOTA (NBEHPM), AND BRAZILIAN FEDERATION OF GASTROENTEROLOGY (FBG)

Barbuti, R. C., Schiavon, L. D. L., de Oliveira, C. P. M. S., Álvares‐da‐Silva, M. R., Sassaki, L. Y., Passos, M. D. C. F., Farias, A. Q., Barros, L. L., Barreto, B. A. P., de Albuquerque, G. B. D. M. L., et al. (2020) · Arquivos de Gastroenterologia · doi:10.1590/s0004-2803.202000000-72 · Cited by 14 · see citing works

Potential tolerability of ancient grains in non-celiac wheat sensitivity patients: A preliminary evaluation

Seidita, A., Mansueto, P., Giuliano, A., Chiavetta, M., Mandreucci, F., Soresi, M., Pistone, M., Compagnoni, S., Castellucci, D., Bisso, G., et al. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.995019 · Cited by 13 · see citing works

Dual epithelial and immune cell function of Dvl1 regulates gut microbiota composition and intestinal homeostasis

Belinson, H., Savage, A. K., Fadrosh, D. W., Kuo, Y., Lin, D. L., Valladares, R. B., Nusse, Y. M., Wynshaw-Boris, A. J., Lynch, S. V., Locksley, R. M., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.85395 · Cited by 12 · see citing works

Changes in Fecal Calprotectin After Rifaximin Treatment in Patients With Nonconstipated Irritable Bowel Syndrome

Lee, S., Kim, C.-R., & Kim, K.-N. (2018) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2018.11.004 · Cited by 12 · see citing works

Unraveling the ties between irritable bowel syndrome and intestinal microbiota

Hong, S. N. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i10.2470 · Cited by 75 · see citing works

The gut microbiome and irritable bowel syndrome: State of art review

Salem, A., Singh, R., Ayoub, Y. K., Khairy, A. M., & Mullin, G. E. (2018) · Arab Journal of Gastroenterology · doi:10.1016/j.ajg.2018.02.008 · Cited by 45 · see citing works

Targeting the gut microbiota for the treatment of irritable bowel syndrome

Herndon, C. C., Wang, Y., & Lu, C. (2019) · The Kaohsiung Journal of Medical Sciences · doi:10.1002/kjm2.12154 · Cited by 52 · see citing works

Emerging Role of the Gut Microbiome in Irritable Bowel Syndrome

Singh, P., & Lembo, A. J. (2021) · Gastroenterology Clinics of North America · doi:10.1016/j.gtc.2021.03.003 · Cited by 39 · see citing works

Intestinal microbiota in pathophysiology and management of irritable bowel syndrome.

(2014) · PubMed Central · doi:10.3748/wjg.v20.i27.8886 · Cited by 106 · see citing works